These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38170194)

  • 1. A review of the contemporary use of inotropes in patients with heart failure.
    Neicheril R; Snipelisky D
    Curr Opin Cardiol; 2024 Mar; 39(2):104-109. PubMed ID: 38170194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative Inotrope Therapy: A Narrative Review.
    Chuzi S; Allen LA; Dunlay SM; Warraich HJ
    JAMA Cardiol; 2019 Aug; 4(8):815-822. PubMed ID: 31268467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology.
    Gustafsson F; Damman K; Nalbantgil S; Van Laake LW; Tops LF; Thum T; Adamopoulos S; Bonios M; Coats AJ; Crespo-Leiro MG; Mehra MR; Filippatos G; Hill L; Metra M; Jankowska E; de Jonge N; Kaye D; Masetti M; Parissis J; Milicic D; Seferovic P; Rosano G; Ben Gal T
    Eur J Heart Fail; 2023 Apr; 25(4):457-468. PubMed ID: 36847113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure.
    Elzeneini M; Aranda JM; Al-Ani M; Ahmed MM; Parker AM; Vilaro JR
    Heart Fail Rev; 2021 Mar; 26(2):355-361. PubMed ID: 32997214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropes.
    Francis GS; Bartos JA; Adatya S
    J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
    Shabana A; Dholoo F; Banerjee P
    Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status of Inotropes in Heart Failure.
    Ginwalla M; Tofovic DS
    Heart Fail Clin; 2018 Oct; 14(4):601-616. PubMed ID: 30266368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B; Buzon J; Kimmoun A
    Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system.
    Samuels LE; Kaufman MS; Thomas MP; Holmes EC; Brockman SK; Wechsler AS
    J Card Surg; 1999; 14(4):288-93. PubMed ID: 10874615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
    Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medical treatment of cardiogenic shock: cardiovascular drugs.
    De Backer D; Arias Ortiz J; Levy B
    Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations.
    McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology.
    Kalogeropoulos AP; Marti CN; Georgiopoulou VV; Butler J
    J Card Fail; 2014 Aug; 20(8):593-601. PubMed ID: 24879975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Inotrope Therapy in Hospice Care: A Case Series.
    Patel K; D'Souza A; Groninger H
    Am J Hosp Palliat Care; 2019 Jul; 36(7):660-663. PubMed ID: 30630349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Palliative inotrope therapy in advanced heart failure: organization and management].
    Gorni G; Correale M; Nodari S; Sinagra G
    G Ital Cardiol (Rome); 2020 Apr; 21(4):296-302. PubMed ID: 32202562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.